MPO and ulcerative colitis: Similarly, our results revealed that i.c.v. injection of HO reduced clinical symptoms associated with ulcerative colitis in DSS-exposed mice, including body weight change, fecal blood, diarrhea, colon shortening, and DAI scores, as well as histological damage scores, MPO, and inflammatory biomarkers.